Inaugural Ramin Tadayoni Award will be granted at 2024 EURETINA Congress
The prize, presented by EURETINA and supported by Oculis, will recognise outstanding contributions to retina research
Novel tactile bottle neck adaptor facilitates eye drop adherence for patients with visual impairment
The adaptor was tested by low-vision patients and participants with simulated visual impairment
RetinAI Discovery from Ikerian receives Class IIa MDR registration in EU
The diagnostic and monitoring tools use artificial intelligence-based models
Artificial intelligence as patient resource: findings from a chatbot investigation
Ophthalmologists graded AI bots' answers to questions from patients following cataract surgery
Aurion Biotech candidate AURN001 receives US Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy Designation
The US Food and Drug Administration issued designations for the allogeneic cell therapy candidate, a therapeutic for corneal oedema
The 36th annual International Congress of German Ophthalmic Surgery (DOC) comes to Nuremberg
Sustainability, artificial intelligence and economic considerations are hot topics at this year’s meeting
Beacon Therapeutics treats first patient in global registration trial for X-linked retinitis pigmentosa therapeutic
XLRP often leads to blindness by middle age with no treatment options currently available
Paediatric case study suggests genetic syndrome link associated with ocular tumor
Investigators say the discovery highlights the importance of genetic consultation
Combining imaging modalities could enable earlier identification of diabetic retinopathy
The mapping method revealed prominent microscopic abnormalities consistent with DR
Why imaging is key to managing geographic atrophy
Paying attention to high-resolution OCT is more important than ever
NIDEK announces CE mark for IOL injector, launch of new OCT device
The NP-1/NP-1C preloaded IOL injector has already been made available in parts of Asia
Metabolomics and the molecular approach to glaucoma diagnosis
Metabolomics reflects the physiological state of a tissue and provides information about interactions between genetics, environment and lifestyle
New therapeutic targets, drug development for retinitis pigmentosa
Simply slowing disease progression is no longer enough
Recap: The Association for Research in Vision and Ophthalmology takes Seattle
ARVO attendees took a deep dive into trends and explored the near future of vision science
Factors affecting ROP development in first 8 weeks after birth
Study could influence screening protocols for neonatal patients
Risk factors for retinal detachment in Marfan syndrome after paediatric lens removal
Investigators put forth a list of considerations for surgeons ahead of lens removalin paediatric patients
A safe and effective non-ablative treatment with multiple applications for the ocular surface
Plasma emission can act as a therapeutic for blepharitis, dry eye and other ocular disease
Topical drop treatment for full-thickness macular hole closure
Investigators reported findings from the first study of successful macular hole closure using topical therapy
Safety and efficacy findings from the XEN45 glaucoma implant
Investigators assessed the XEN45 implant alone and in combination with phacoemulsification
SLT delivery by non-medical ophthalmic practitioners serves patients with glaucoma
Early results indicate that trained optometrists delivered safe and effective laser treatments
Espansione Group receives CE Mark approval for eye-light® photobiomodulation device
The flagship, light-based technology has received approval for applications in the anterior and posterior segments
Global leaders in cataract run the Olympic gauntlet of surgery
Surgeons shared practical pearls in a “Cataract Olympiad"
The 16th European Glaucoma Society Congress convenes in Dublin
This year’s meeting will take place in Ireland’s technology and business hub
Monitoring glaucoma progression rate to preserve patients’ vision
Three approaches to examination give a comprehensive overview
European Commission grants Marketing Authorisation for bevacizumab gamma
The approval also grants Outlook Therapeutics an initial 10 years of market exclusivity in the EU for bevacizumab gamma (LYTENAVA)
Dopavision announces topline results for MyopiaX trial for slowing paedatric myopia progression
The light-based therapy functions using a virtual reality headset
Racing against microbial keratitis
Challenging choices force ophthalmologists to weigh long-term outcomes
Role of ferroptosis in bacterial keratitis
Inhibiting ferroptosis could be crucial to reducing inflammation
Post hoc analysis shows how pegcetacoplan may impact RPE atrophy
Analysis of the OAKS and DERBY trials showed reduced growth rates of SD-OCT biomarkers for geographic atrophy
Professor Noemi Lois awarded Edinburgh King James IV Professorship by The Royal College of Surgeons
Professor Lois accepted the award at the Royal College of Ophthalmologists Annual Congress